- Home
- RXST vs NFJ Comparison
RXST vs NFJ Comparison
Compare RXST & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXST
- NFJ
- Stock Information
- Founded
- RXST 1997
- NFJ 2005
- Country
- RXST United States
- NFJ United States
- Employees
- RXST N/A
- NFJ N/A
- Industry
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NFJ Finance: Consumer Services
- Sector
- RXST Health Care
- NFJ Finance
- Exchange
- RXST Nasdaq
- NFJ Nasdaq
- Market Cap
- RXST 1.0B
- NFJ 1.2B
- IPO Year
- RXST 2021
- NFJ N/A
- Fundamental
- Price
- RXST $26.56
- NFJ $12.09
- Analyst Decision
- RXST Strong Buy
- NFJ
- Analyst Count
- RXST 9
- NFJ 0
- Target Price
- RXST $49.33
- NFJ N/A
- AVG Volume (30 Days)
- RXST 552.2K
- NFJ 223.5K
- Earning Date
- RXST 05-05-2025
- NFJ 01-01-0001
- Dividend Yield
- RXST N/A
- NFJ 9.01%
- EPS Growth
- RXST N/A
- NFJ N/A
- EPS
- RXST N/A
- NFJ N/A
- Revenue
- RXST $139,927,000.00
- NFJ N/A
- Revenue This Year
- RXST $38.53
- NFJ N/A
- Revenue Next Year
- RXST $24.60
- NFJ N/A
- P/E Ratio
- RXST N/A
- NFJ N/A
- Revenue Growth
- RXST 57.09
- NFJ N/A
- 52 Week Low
- RXST $24.09
- NFJ $10.45
- 52 Week High
- RXST $66.54
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- RXST 48.13
- NFJ 36.53
- Support Level
- RXST $24.24
- NFJ $12.07
- Resistance Level
- RXST $27.13
- NFJ $12.29
- Average True Range (ATR)
- RXST 1.06
- NFJ 0.14
- MACD
- RXST 0.35
- NFJ 0.01
- Stochastic Oscillator
- RXST 81.25
- NFJ 37.90
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. Its primary investment objective is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.